Advanced search
Publication Cover
Clinical Toxicology Volume 55, 2017 - Issue 1
Submit an article Journal homepage
798
Views
21
CrossRef citations to date
0
Altmetric
Clinical Research

Clinical effects of unintentional pediatric buprenorphine exposures: experience at a single tertiary care center

Michael S. ToceHarvard Medical Toxicology Program, Boston Children’s Hospital, Boston, MA, USA; Correspondence[email protected]
,
Michele M. BurnsHarvard Medical Toxicology Program, Boston Children’s Hospital, Boston, MA, USA; ;Division of Emergency Medicine, Department of Medicine, Boston Children’s Hospital, Boston, MA, USA;
&
Katherine A. O’DonnellHarvard Medical Toxicology Program, Boston Children’s Hospital, Boston, MA, USA; ;Division of General Pediatrics, Department of Medicine, Boston Children’s Hospital, Boston, MA, USA
Pages 12-17 | Received 15 Jun 2016, Accepted 24 Sep 2016, Published online: 19 Oct 2016

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Stephanie Carreiro, Simone Miller, Bo Wang, Paul Wax, Sharan Campleman & Alex F. Manini. (2020) Clinical predictors of adverse cardiovascular events for acute pediatric drug exposures. Clinical Toxicology 58:3, pages 183-189.
Read now

Articles from other publishers (20)

James D. Whitledge, Christopher James Watson, Michael D. Simpson & Michele M. Burns. (2023) A Disturbing Diagnosis to Consider. Pediatric Emergency Care 39:12, pages e90-e91.
Crossref
Claire Cowans, Anya Love, Balamurugan Tangiisuran & Sabrina Anne Jacob. (2023) Uncovering the Hidden Burden of Pharmaceutical Poisoning in High-Income and Low-Middle-Income Countries: A Scoping Review. Pharmacy 11:6, pages 184.
Crossref
Rena Eudy‐Byrne, Nicole Zane, Susan C. Adeniyi‐Jones, Marc R. Gastonguay, Ana Ruiz‐Garcia, Gagan Kaushal & Walter K. Kraft. (2021) Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome. Clinical and Translational Science 14:6, pages 2171-2183.
Crossref
Michelle R. Lofwall & Laura C. Fanucchi. (2021) Long-acting buprenorphine injectables: Opportunity to improve opioid use disorder treatment among rural populations. Preventive Medicine 152, pages 106756.
Crossref
Michael Levine & Frank Lovecchio. (2021) New Designer Drugs. Emergency Medicine Clinics of North America 39:3, pages 677-687.
Crossref
Michael S. Toce, Eli Freiman, Katherine A. O’Donnell & Michele M. Burns. (2021) Clinical Effects of Pediatric Clonidine Exposure: A Retrospective Cohort Study at a Single Tertiary Care Center. The Journal of Emergency Medicine 60:1, pages 58-66.
Crossref
Martin Krsak, Brian T Montague, Paul Trowbridge, Steven C Johnson & Ingrid A Binswanger. (2020) Opioid Use and Chronic Infections: The Value of Addressing the Syndemic in Correctional Settings Via Telemedicine Guidance and Broader Use of Long-Acting Medications. The Journal of Infectious Diseases 222:Supplement_5, pages S486-S493.
Crossref
Alberto Bianco, Yuan Chen, Elzbieta Frackowiak, Michael Holzinger, Nikhil Koratkar, Vincent Meunier, Sergey Mikhailovsky, Michael Strano, Juan M.D. Tascon & Mauricio Terrones. (2020) Carbon science perspective in 2020: Current research and future challenges. Carbon 161, pages 373-391.
Crossref
Saumitra V. Rege, Duc Anh Ngo, Nassima Ait-Daoud, Justin Rizer, Sana Sharma & Christopher P. Holstege. (2020) Epidemiology of pediatric buprenorphine and methadone exposures reported to the poison centers. Annals of Epidemiology 42, pages 50-57.e2.
Crossref
C. James Watson, James D. Whitledge, Alexander F. Barbuto, Katherine L. Boyle & Michael Ganetsky. (2020) Toxicity of agents used for opioid withdrawal: a case-based approach. International Anesthesiology Clinics 58:2, pages 19-27.
Crossref
Michael Frost, Genie L. Bailey, Nicholas Lintzeris, John Strang, Adrian Dunlop, Edward V. Nunes, Jakob Billeskov Jansen, Lars Chemnitz Frey, Bernd Weber, Paul Haber, Sonia Oosman, Sonnie Kim & Fredrik Tiberg. (2019) Long‐term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out‐patients with opioid use disorder. Addiction 114:8, pages 1416-1426.
Crossref
Jean-Marie Nicolas & Elizabeth C. M. de Lange. (2019) Mind the Gaps: Ontogeny of Human Brain P-gp and Its Impact on Drug Toxicity. The AAPS Journal 21:4.
Crossref
Meike Lo Re, Margaret Chaplin, Benjamin Aronow & Vania Modesto-Lowe. (2019) Buprenorphine Overdose in Young Children: An Underappreciated Risk. Clinical Pediatrics 58:6, pages 613-617.
Crossref
Michael S. Toce, Peter R. Chai, Michele M. Burns & Edward W. Boyer. (2018) Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity. Journal of Medical Toxicology 14:4, pages 306-322.
Crossref
Kristin J. Roberts, Suzanne Tomasi, Jason W. Stull, Lara B. McKenzie & Henry A. Spiller. (2018) Veterinary-Prescribed Buprenorphine Ingestion in a 2-Year-Old Girl. Pediatric Emergency Care Publish Ahead of Print.
Crossref
George Sam WangS. Geoffrey SevertsonGabrielle E. BauRichard C. Dart & Jody L. Green. (2018) Unit-Dose Packaging and Unintentional Buprenorphine-Naloxone Exposures. Pediatrics 141:6.
Crossref
Michelle R. Lofwall, Sharon L. Walsh, Edward V. Nunes, Genie L. Bailey, Stacey C. Sigmon, Kyle M. Kampman, Michael Frost, Fredrik Tiberg, Margareta Linden, Behshad Sheldon, Sonia Oosman, Stefan Peterson, Michael Chen & Sonnie Kim. (2018) Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder. JAMA Internal Medicine 178:6, pages 764.
Crossref
Hannah R. Fudin, Jennifer L. Babin, Lisa T. Hong, Jennifer Ku, Alisyn L. May, Alexander Wisner, F. Scott Hall & Sidhartha D. Ray. 2018. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 29 89 .
Walter K. Kraft. (2018) Buprenorphine in Neonatal Abstinence Syndrome. Clinical Pharmacology & Therapeutics 103:1, pages 112-119.
Crossref
Neeraj Chhabra & Steven E. Aks. (2017) Current Opiate and Opioid Hazards in Children and Adolescents. Clinical Pediatric Emergency Medicine 18:3, pages 173-180.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.